Copyright
©The Author(s) 2021.
World J Gastroenterol. Oct 28, 2021; 27(40): 6908-6926
Published online Oct 28, 2021. doi: 10.3748/wjg.v27.i40.6908
Published online Oct 28, 2021. doi: 10.3748/wjg.v27.i40.6908
Forward | Reverse | |
siGlut1-1 | 5′-CACCGGGAGTGACAAAGACTTTGTTCAAGCA-3′ | 5′-GATCCAAAAAAGGGAGTGACAAAGACTTCTC-3′ |
Negative control | 5′-ATCCGACTTCATAAGGCGCATGCT-3′ | 5′-AGTATTCCGCGTACGAAGTTCTGC-3′ |
siRNA Smad4 targeting four different sequences1 | ||
GCAAUUGAAAGUUUGGUAA, CCCACAACCUUUAGACUGA, GAAUCCAUAUCACUACGAA and GUACAGAGUUACUACUUAG | ||
siRNA Smad2/31 | Sense | Antisense |
sc-37239A | CUUGCUGGAUUGAACUUCAtt | UGAAGUUCAAUCCAGCAAGtt |
sc-37239B | CCGUCGUAGUAUUCAUGUAtt | UACAUGAAUACUACGACGGtt |
sc-37239C | CUGACUCCUUGUUUAAUGAtt | UCAUUAAACAAGGAGUCAGtt |
sc-37239D | GGAAGCUGAGAGUUAUAGAtt | UCUAUAACUCUCAGCUUCCtt |
- Citation: Zhou MY, Cheng ML, Huang T, Hu RH, Zou GL, Li H, Zhang BF, Zhu JJ, Liu YM, Liu Y, Zhao XK. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells. World J Gastroenterol 2021; 27(40): 6908-6926
- URL: https://www.wjgnet.com/1007-9327/full/v27/i40/6908.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i40.6908